Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Download your Brochure
Reserve your place

Where data empowers pharma, payers and key stakeholders toward a shared purpose – Europe’s only home for RWE, data and access leaders.

Data dictates payer decisions and has the potential to provide a new guiding light for pharma companies. We want to create a summit that catalyses the healthcare landscape into a new world. A place complete with real-world insights, aiding in the creation of true value in the eyes of the payers and regulators, and allowing patients the access to the drugs and treatments they need most.

At the Real-World Evidence and Access Europe 2018 Summit We will once again bring together the leading thought leaders and biggest industry case studies from across the continent, while also moving to ensure that speaking and participating will be all the key decision-makers in full stakeholder environment – complete with regulators, payers and HTAs.

Key learnings and takeaways include:

  • Unite stakeholders:
    accelerate transition to a new data-led world by aligning pharma, payers and HTA around shared healthcare goals
  • Data is differentiation:
    enhance your real-world study and analytical capabilities to provide sharper insights
  • Access first:
    Create a market access led culture and strategy within development teams to meet payer evidence demands
  • Resurrect risk-sharing:
    ensure reimbursement through smart agreements that enable you to win through your higher-value offering
  • Accelerate patient access:
    use superior data insights to achieve earlier access through demonstrable unmet need

Complete speaker line-up • Program for all tracks & sessions • Audience breakdown

Download the detailed event brochure here

2018 Speakers already confirmed:

Market Access

Gillian Leng

NICE

Deputy Chief Executive

Steve Wooding

Janssen

Head, Global Commercial and Market Access Strategy Organisation

Isabel Torres

Takeda

Vice President Market Access, Public Affairs and Patient Advocacy for Europe and Canada

Pernille Storm
Pernille Storm

Lundbeck

Global Market Access Director, Neurology

Real-World Evidence

Martin Gibson

NIHR

Director Greater Manchester

Enkeleida Nikai-Fitzgerald

Eli Lilly and Company

Director of Real World Evidence

Bart Vannieuwenhuyse
Bart Vannieuwenhuyse

Janssen

Senior Director Health Information Sciences

Sajan Khosla

AstraZeneca

Head of Real World Evidence, Centre of Excellence

Be the first to see the 2018 speaker line-up, download the brochure here

Download the detailed event brochure here

The industry’s chosen themes for 2018:

The 2018 summit will bring you 2 conferences in one.

One completely dedicated to market access, innovative pricing and re-imbursement and the other track dedicated to expanding the use of RWE internally across functions and influencing external decision makers

To get the full agenda for both the RWE and Access tracks, download the brochure here

Download the detailed event brochure here

What our delegates are saying

Make sure you join them in the discussion in 2018, download the brochure here

Download the detailed event brochure here

Got a question? Get in touch below!

If you’re interested in getting involved in the 2018 summit, please contact us on the details below.

James Mackintosh

James Mackintosh

Global Project Director
eyeforpharma

Phone: +44 (0) 207 375 7163

Email: jmackintosh@eyeforpharma.com

Josh Bramwell

Josh Bramwell

Global Project Director
eyeforpharma

Phone: +44 (0) 207 375 7203

Email: jbramwell@eyeforpharma.com